According to GuruFocus' list of five-year lows, these stocks have reached their five-year lows: Global Partners LP (GLP, Financial), Paratek Pharmaceuticals Inc. (PRTK, Financial), KVH Industries Inc. (KVHI, Financial) and LMI Aerospace Inc. (LMIA, Financial).
Global Partners LP reached $13.18
The price of Global Partners LP shares has declined to $13.18, which is only 6.8% above the five-year low of $12.28. It is now 73.2% off the five-year high of $45.75. Global Partners LP is owned by one guru. He reduced his position.
Global Partners LP has a market cap of $448.060 million; its shares were traded around $13.18 with a P/E ratio of 1318.00 and P/S ratio of 0.05. The trailing 12-month dividend yield of Global Partners LP stocks is 17.57%. The forward dividend yield of Global Partners LP stocks is 13.96%. Global Partners LP had an annual average earnings growth of 10.90% over the past 10 years.
Global Partners' stock prices have declined over the past five years.
GuruFocus has recognized two severe warning signs for Global Partners:
- Declining revenue per share.
- Long-term debt.
Global Partners LP announced net sales of $1.8 billion in the first quarter, a decrease from 2015’s first quarter net sales of $3.0 billion due to lower commodity prices and a decline in volume.
Paratek Pharmaceuticals reached $13.25
The price of Paratek Pharmaceuticals shares has declined to $13.25, which is only 9.1% above the five-year low of $12.05. It is now 92.3% off the five-year high of $155.88. Paratek Pharmaceuticals is owned by two gurus we are tracking. They added to their positions during the past quarter. Paratek Pharmaceuticals has a market cap of $235.050 million; its shares were traded around $13.25.
Paratek Pharmaceuticals stock prices have declined over the past five years.
Paratek Pharmaceuticals faces competition from companies such as Abbott Laboratories (ABT, Financial) and Allergan (AGN, Financial). However, the company believes that several of its product candidates, if approved by the FDA, will represent significant competition and capture market share from competitors.
GuruFocus has recognized two severe warning signs for Paratek:
- Low Piotroski F-Score.
- Declining revenue per share.
Paratek Pharmaceuticals reported a net loss of $31.3 million in the first quarter, compared with net loss of $10.6 million for the same period in the previous previous year. The company’s expenses increased from $10.6 million to $30.7 million due to the continuation of research and development, more salaries and benefits and stock-based compensation.
Seth Klarman (Trades, Portfolio) initiated his position in Paratek Pharmaceuticals.
Chairman and CEO Michael Bigham bought 20,000 shares for an average price of $13.45 per share on June 23. Director Richard J. Lim bought 461,538 shares for $13 per share on June 27.
KVH Industries reached $7.46
The price of KVH Industries shares has declined to $7.46, which is only 7.5% above the five-year low of $6.90. It is now 56.3% off the five-year high of $15.79. KVH Industries is owned by two gurus we are tracking. Among them, one have added to his position during the past quarter, and the other reduced his position.
KVH Industries has a market cap of $123.070 million; its shares were traded around $7.46 with a P/E ratio of 186.50 and P/S ratio of 0.66. KVH Industries had an annual average earnings growth of 15.50% over the past 10 years. GuruFocus rated KVH Industries the business predictability rank of 4-star.
KVH Industries stock prices have declined by 32% over the past five years.
KVH Industries currently faces competitions with companies such as Intellian, Orbit Communication Systems and Honeywell International Inc. (HON, Financial). The company expects competition to increase in the future.
GuruFocus has recognized one severe warning sign for KVH Industries:
- Faster asset growth than revenue growth.
KVH Industries recognized revenue of $40.4 million and net loss of $2.8 million in its first-quarter report. This is compared with last year’s first quarter revenue of $41.3 million and net loss of $1.4 million.
LMI Aerospace reached $7.88
The price of LMI Aerospace shares has declined to $7.88, which is only 4.7% above the five-year low of $7.51. It is now 69.3% off the five-year high of $24.45. LMI Aerospace is owned by two gurus we are tracking. Both added to their positions during the past quarter.
LMI Aerospace has a market cap of $106.190 million; its shares were traded around $7.88 with and P/S ratio of 0.29.
LMI Aerospace stock prices have declined over the past five years.
The aerospace industry competes in terms of quality, price, delivery and contract. LMI Aerospace expects for competition to increase in the future from foreign sources because of their access to low cost labor.
GuruFocus has recognized two severe warnings signs for LMI Aerospace:
- Declining gross margin.
- Faster asset growth than revenue growth.
In its first-quarter results, LMI Aerospace reported net sales of $87.3 million and net loss of $1.8 million. This is compared with net sales of $92.5 million and net loss of $1.5 million for its 2015 first quarter.
Go here for the complete list of five-year lows.
Start a free seven-day trial of Premium Membership to GuruFocus.
